tirzepatide apnea FDA approves to treat sleep Clinical Capsules: Zepbound for Zzz's:

The company states that prescription approval is not guaranteed and that some patients may not qualify based on medical contraindications or other factors

patients should be counseled to report symptoms such as neck mass, dysphagia, or persistent hoarseness Contraindication : Personal or family history of MTC or MEN2 Gallbladder disease : Tirzepatide may increase risk of gallstones and cholecystitis Acute kidney injury : Dehydration from gastrointestinal adverse effects may impair renal function Pancreatitis : Patients should be counseled to report severe, persistent abdominal pain Niacin-specific safety concerns: Hepatotoxicity : Baseline liver function tests and monitoring during dose titration and periodically thereafter are recommended

In 2023, the FDA added a new warning about the potential of ileus when taking semaglutide

Here's the math: Desired Dose: 0.5mg Concentration: 5mg/mL Calculation: (Desired Dose) / (Concentration) = Volume to Draw (0.5mg) / (5mg/mL) = 0.1mL So, you would need to draw 0.1mL of the solution into your insulin syringe